FDA.reportPublic FDA data

emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG (equivalent to tenofovir disoproxil 163 MG) Oral Tablet

RxCUI
1744005
RxNorm name
emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG (equivalent to tenofovir disoproxil 163 MG) Oral Tablet
Display name
emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG (equivalent to tenofovir disoproxil 163 MG) Oral Tablet
Full name
emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG (equivalent to tenofovir disoproxil 163 MG) Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:59

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TruvadaEMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEGilead Sciences, Inc54e82b13-a037-49ed-b4b3-030b37c0ecdd2025-07-16Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1744005
Emtricitabine and tenofovir disoproxil fumarateEMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEZydus Lifesciences Limiteda0ee89b6-72c3-4b99-8d1c-d7473f1d5ef32024-11-28Exact identifier
rxcui: 1744005
Emtricitabine and tenofovir disoproxil fumarateEMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEZydus Pharmaceuticals USA Inc.7def7a95-e69e-4985-974a-efacadcecc952024-05-10Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1744005
Emtricitabine and Tenofovir Disoproxil FumarateEMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEAurobindo Pharma Limited974d2ec8-1b51-4e69-991d-0d5dea8360f42024-01-03Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1744005
Emtricitabine and Tenofovir Disoproxil FumarateEMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEAmneal Pharmaceuticals NY LLCb0459301-2bff-4336-9172-b90c7a5824332020-11-29Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1744005

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 6 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
54e82b13-a037-49ed-b4b3-030b37c0ecddemtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG Oral Tablet [PSN] · emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG Oral Tablet [SCD] · emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG (equivalent to tenofovir disoproxil 163 MG) Oral Tablet [SY]332These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 200420250716
b0459301-2bff-4336-9172-b90c7a582433emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG Oral Tablet [PSN] · emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG Oral Tablet [SCD] · emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG (equivalent to tenofovir disoproxil 163 MG) Oral Tablet [SY]39These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200420201129
7def7a95-e69e-4985-974a-efacadcecc95emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG Oral Tablet [PSN] · emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG Oral Tablet [SCD] · emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG (equivalent to tenofovir disoproxil 163 MG) Oral Tablet [SY]38These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200420240510
a0ee89b6-72c3-4b99-8d1c-d7473f1d5ef3emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG Oral Tablet [PSN] · emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG Oral Tablet [SCD] · emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG (equivalent to tenofovir disoproxil 163 MG) Oral Tablet [SY]36Emtricitabine and Tenofovir Disoproxil Fumarate Tablets20241128
70b3deb4-951d-4d9b-a811-be5fa05529a9emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG Oral Tablet [PSN] · emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG Oral Tablet [SCD] · emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG (equivalent to tenofovir disoproxil 163 MG) Oral Tablet [SY]33These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200420200720
974d2ec8-1b51-4e69-991d-0d5dea8360f4emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG Oral Tablet [PSN] · emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG Oral Tablet [SCD] · emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG (equivalent to tenofovir disoproxil 163 MG) Oral Tablet [SY]32These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200420240103